Mounting criticism labels South Africa’s controversial National Health Insurance (NHI) plan not as a lifeline for a broken system. Instead, critics see it as a meticulously planned manoeuvre to centralise control over a budget exceeding R1 trillion. Opponents argue...
A groundbreaking, twice-yearly injection for HIV prevention is hailed as a potential ‘game-changer’. However, it is at the centre of a fierce debate regarding affordability. Health activists worldwide implore its manufacturer, Gilead Sciences, to prevent a...
In a decision that could fundamentally reshape the fight against HIV, the US Food and Drug Administration (FDA) has given its approval to Gilead Sciences’ lenacapavir, a groundbreaking twice-yearly injection for preventing HIV infection in adults and...
Gauteng’s health authorities are sounding the alarm as the province grapples with a significant increase in measles cases. Since the beginning of 2025, health officials have reported a worrying 181 laboratory-confirmed cases. The epicentres of the outbreak are...
The familiar misery of a runny nose, itchy eyes, and worsening asthma symptoms for hay fever sufferers is set to become even more pervasive, as experts warn of an “explosion” of allergies driven by a shifting climate. The World Meteorological Organisation (WMO) has...
